Compounds > n-acetylneuraminic acid

n-acetylneuraminic acid and Focal Segmental Glomerulosclerosis

n-acetylneuraminic acid has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Isome, M; Kawasaki, Y; Nozawa, R; Nozawa, Y; Sakai, N; Suzuki, H; Suzuki, J; Tannji, M1

Other Studies

1 other study(ies) available for n-acetylneuraminic acid and Focal Segmental Glomerulosclerosis

ArticleYear
FB21, a monoclonal antibody that reacts with a sialic-acid-dependent carbohydrate epitope, is a marker for glomerular endothelial cell injury.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 44, Issue:2

    Topics: Adult; Age Factors; Antibodies, Monoclonal; Antibody Specificity; Antigens, Surface; Biomarkers; Child; Child, Preschool; E-Selectin; Endothelial Cells; Endothelium, Vascular; Epitopes; Female; Gestational Age; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, Focal Segmental; Hemolytic-Uremic Syndrome; Humans; IgA Vasculitis; Immunoenzyme Techniques; Immunohistochemistry; Kidney Glomerulus; Male; Microscopy, Immunoelectron; Middle Aged; N-Acetylneuraminic Acid; Streptococcal Infections

2004